Leonardo Clavijo is a Cardiology physician affiliated with St. Helena Hospital. OpenAlex indexes 147 publications with 3,525 citations (h-index 23); ClinicalTrials.gov lists 5 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingClinical trials
- Effect of Evolocumab in Patients With Critical Limb Ischemia (Evol-CLI)
Sponsor: Leonardo Clavijo
- Aspirin and Clopidogrel Reactivity in Patients With Critical Limb Ischemia (CLI)
Sponsor: University of Southern California
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
73.1%Beta blocker22%Metoprolol Succinate59%Carvedilol20%Metoprolol Tartrate16%Atenolol3%Sotalol2%Part D<11 patientsStatin11.9%Atorvastatin Calcium53%Rosuvastatin Calcium34%Simvastatin8%Pravastatin Sodium6%Part D<11 patients+ 15 more classes in this area
Blood & clotting
19.9%Factor Xa inhibitor10%Eliquis82%Xarelto18%Part D≥72 patientsP2Y12 inhibitor9.5%Clopidogrel96%Brilinta4%Part D<11 patients+ 1 more class in this area
Metabolism & gastrointestinal
4.8%Potassium supplement3.6%Potassium Chloride100%Part D≥32 patientsSGLT2 inhibitor0.8%Jardiance100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Surgery or Endovascular Therapy for Chronic Limb-Threatening Ischemia
New England Journal of Medicine
2022
Similar KOLs
Other experts from the same institution or the same specialty.
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”